SCHEMBL1734424

SCHEMBL1734424

CC(C)CNc1nc(C(N)=O)cc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ADORA1 P30542 6/20 0.52
HRH4 Q9H3N8 4/20 0.52
GLA P06280 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HTT P42858 2/20 0.47
FPR2 P25090 1/20 0.47
SCN9A Q15858 1/20 0.47
HSD17B10 Q99714 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
ADORA3 P0DMS8 2/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
VCP P55072 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1734504 0.88 KDM4E (0.51) KDM4EADORA1HRH4GLAALDH1A1
SCHEMBL1735703 0.85 KDM4E (0.49) KDM4EADORA1HRH4GLAALDH1A1
SCHEMBL1734332 0.85 KDM4E (0.60) KDM4EADORA1GLAALDH1A1HPGD
SCHEMBL1734127 0.83 KDM4E (0.57) KDM4EADORA1GLAALDH1A1HPGD
SCHEMBL1734267 0.83 PIK3CB (0.57) KDM4EHRH4GLAALDH1A1HPGD
SCHEMBL1733575 0.83 FPR2 (0.55) KDM4EADORA1GLAALDH1A1HPGD
SCHEMBL1734467 0.82 KDM4E (0.53) KDM4EADORA1GLAALDH1A1HPGD
SCHEMBL1733664 0.81 TDP1 (0.65) KDM4EADORA1GLAALDH1A1HPGD
SCHEMBL1734521 0.80 HRH1 (0.52) KDM4EADORA1HRH4GLAALDH1A1
SCHEMBL1735520 0.80 KDM4E (0.56) KDM4EADORA1GLAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891018-B1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2011-11-16 EP claimed
WO-2011131686-A1 A THERMALLY CONTROLLED ASSEMBLY NAPATECH A/S (DK) 2011-10-27 WO claimed
EP-1891018-A2 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals, Inc. (US) 2008-02-27 EP claimed
US-20070105833-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2007-05-10 US claimed
WO-2006127588-A2 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-11-30 WO claimed
US-8822451-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-02 US disclosed
US-8822451-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-02 US disclosed
US-20070105833-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2007-05-10 US disclosed
US-20070105833-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105833-A1 Modulators of ATP-binding cassette transporters ABCC4, CFTR, ABCC2 KDM4E 3910/4885ADORA1 142/4885HRH4 1734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.